drugset / Trial / NCT00892450
Anticholinergic Therapy for Overactive Bladder in Parkinson's Disease
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this research study is to investigate the cognitive (thinking, memory, knowledge, intelligence) side effects of two medications commonly used to treat overactive bladder (OAB) symptoms in veteran patients with Parkinson's disease (PD) seen at the Philadelphia PADRECC.
Timeline
- Start
- 2009-05
- Primary completion
- 2014-09
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Darifenacin | Small molecule | — | — |
| Subject | Oxybutynin | Small molecule | — | — |